[Insights and views about cardiovascular safety of COX2 inhibitors].
Wallentin
Lars
L
Uppsala kliniska forskningscentrum (UCR). lars.wallentin@ucr.uu.se
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D035843:Biomedical Research; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D004345:Drug Industry; D006801:Humans; D012449:Safety
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors